Home › Prostaatkanker › Wisconsin › Madison
Prostaatkanker klinische studies in Madison, WI
29 studies voor Prostaatkanker zoeken deelnemers op locaties in en rond Madison (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruterenFase 1/2
- University of Wisconsin Carbone Cancer Center, Madison
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
RekruterenFase 3
- William S Middleton VA Medical Center, Madison
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- William S Middleton VA Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
PET/CT Characterization of Treatment Resistance
Rekruteren
- University of Wisconsin, Madison
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
RekruterenFase 3
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
RekruterenFase 2
- William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
RekruterenFase 2
- William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
RekruterenFase 3
- University Hospital and UW Health Clinics ( Site 0065), Madison
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)
RekruterenFase 2
- Carbone Cancer Center University of Wisconsin-Madison, Madison
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
RekruterenFase 3
- University of Wisconsin, Madison
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RekruterenFase 3
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
RekruterenFase 2
- UW Health Carbone Cancer Center, Madison
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
RekruterenObservatieonderzoek
- University of Wisconsin Carbone Cancer Center, Madison
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
RekruterenFase 2
- University of Wisconsin Carbone Cancer Center-Madison, Madison
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
RekruterenFase 3
- William S Middleton VA Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- University of Wisconsin, Carbone Cancer Center, Madison
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
RekruterenFase 1
- University of Wisconsin Carbone Cancer Center, Madison
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
RekruterenObservatieonderzoek
- University of Wisconsin-Madison, Madison
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RekruterenFase 3
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
RekruterenFase 2
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
RekruterenFase 1
- University of Wisconsin, Madison
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
RekruterenFase 1
- University of Wisconsin Carbone Cancer Center, Madison
Using FAPI PET/MRI to Evaluate Prostate Cancer
RekruterenFase 2
- University of Wisconsin, Madison
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
RekruterenObservatieonderzoek
- University of Wisconsin Carbone Cancer Center, Madison
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
RekruterenFase 2/3
- William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer
RekruterenFase 1
- University of Wisconsin Carbone Cancer Center (UWCCC) - Cancer Connect, Madison
Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC
RekruterenFase 1
- University of Wisconsin - Madison, Madison
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
RekruterenFase 4
- University of Wisconsin, Madison
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
RekruterenObservatieonderzoek
- University of Wisconsin-Madison, Madison
Prostaatkanker studies in andere steden
- New York City, NY103 studies
- Houston, TX76 studies
- Los Angeles, CA61 studies
- Boston, MA59 studies
- St. Louis, MO46 studies
- Chicago, IL45 studies
- San Francisco, CA45 studies
- Philadelphia, PA44 studies
- Baltimore, MD43 studies
- Nashville, TN42 studies
- Seattle, WA42 studies
- Washington, DC38 studies
Andere studies in Madison
- Colorectale kanker22 studies
- Borstkanker22 studies
- Metastatische kanker21 studies
- Niet-kleincellige longkanker16 studies
- Acute myeloïde leukemie16 studies
- Melanoom15 studies
- Kanker (alle vormen)14 studies
- Eierstokkanker13 studies
- Maagkanker11 studies
- Longkanker10 studies
- Aldermeesklierkanker10 studies
- Multipel myeloom9 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.